Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 405 of 5804
-
Can a glucose monitor boost diabetes remission? new trial aims to find out
Disease control Not yet recruitingThe goal of the study is to evaluate the effectiveness of intermittently scanned continuous glucose monitoring compared to capillary blood glucose monitoring among people with type 2 diabetes initiating low calorie meal replacement plus diabetes self-management education in impro…
Phase: NA • Sponsor: LMC Diabetes & Endocrinology Ltd. • Aim: Disease control
Last updated Jun 26, 2026 14:23 UTC
-
Nearly 10,000 heart attack patients to test ancient pill for better recovery
Disease control Not yet recruitingThis study aims to evaluate the value of Shexiang Baoxin Pill (MUSKARDIA) in patients with acute myocardial infarction (AMI) through a prospective, multicenter, pragmatic randomized controlled real-world study. It seeks to validate its efficacy in reducing cardiovascular event ri…
Phase: PHASE4 • Sponsor: Shanghai Hutchison Pharmaceuticals Limited • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC
-
New AI tool could spot dangerous liver cancer invasion without a biopsy
Diagnosis Recruiting nowHepatocellular carcinoma (HCC) is a common malignancy in China with a high mortality rate. Its early recurrence and long-term prognosis are closely associated with tumor aggressiveness. Microvascular invasion (MVI), defined as the presence of tumor cells within small branches of …
Sponsor: Chinese Academy of Sciences • Aim: Diagnosis
Last updated Jun 26, 2026 15:47 UTC
-
New pill targets Hard-to-Treat prostate cancer
Disease control Not yet recruitingTQB3201 is an orally administered targeted protein chimera (PROTAC) drug in which one end of the drug is attached to a ligand that binds to Androgen Receptor (AR) and the other end to a ligand of E3 ligase (CRBN) via a linker. The phase I phase of this trial aims to evaluate the …
Phase: PHASE1, PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 17:15 UTC
-
New gel could ease blistering for skin disorder patients
Disease control Recruiting nowThis Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (4 years of age and older) diagnosed with generalized intermediate to severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) …
Phase: PHASE2 • Sponsor: BioMendics, LLC • Aim: Disease control
Last updated Jun 26, 2026 15:57 UTC
-
AI body scans could make chemo safer for women with ovarian and endometrial cancer
Disease control Not yet recruitingThe dosage of paclitaxel, an adjuvant chemotherapy agent for endometrial and ovarian cancer, is typically calculated based on the patient's body surface area (BSA). However, cancer patients with the same BSA may exhibit significant differences in body composition, which could inf…
Phase: NA • Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug cocktail aims to shrink Hard-to-Treat breast tumors
Disease control Not yet recruitingThis is an open-label, single-arm, multicenter phase II study to evaluate the safety and efficacy of sac-TMT plus Tagitanlimab in patients with PD-L1-positive locally advanced or metastatic TNBC.
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:58 UTC
-
Drug cocktail aims to shrink stomach tumors before surgery in small trial
Disease control Not yet recruitingEfficacy and safety of Iparomlimab and Tuvonralimab in combination with lenvatinib and SOX chemotherapy in potentially resectable MSI-H, dMMR locally advanced gastric or gastroesophageal junction adenocarcinoma patients: A prospective, multicenter, open-label Phase II single-arm …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 26, 2026 13:09 UTC
-
Brain cancer breakthrough? new device zaps tumors during surgery
Disease control Recruiting nowGlioblastoma is the most aggressive primary brain tumor due to its highly infiltrative growth pattern, strong proliferative potential, and multiple mechanisms of resistance to treatment . Based on results from multicenter studies, English oncologist Roger Stupp proposed in 2005 a…
Phase: PHASE1 • Sponsor: Joint Stock Company European Medical Centre • Aim: Disease control
Last updated Jun 26, 2026 17:41 UTC
-
New hope for rare lymphoma: drug combo targets tough cancer
Disease control Not yet recruitingEvaluation of the Safety and Efficacy of Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS.
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hope for advanced liver cancer: drug combo shows promise
Disease control Not yet recruitingPatients with locally advanced unresectable or metastatic hepatocellular carcinoma (HCC) who progressed after prior systemic therapy (targeted ± immunotherapy) are enrolled. Primary endpoint: objective response rate (ORR). Planned enrollment: 47 subjects. Eligible patients receiv…
Phase: PHASE2 • Sponsor: Song Peng • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
AI could turn routine chest scans into heart attack predictors
Diagnosis Recruiting nowCoronary artery disease (CAD) is one of the leading causes of death worldwide. Many people have early atherosclerosis without symptoms, and some may develop significant coronary stenosis before any warning signs appear. Identifying high-risk individuals at an early stage is impor…
Sponsor: Yifan Guo • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
AI reads chest x-rays to catch TB earlier in china
Diagnosis Recruiting nowThe global incidence rate and mortality of tuberculosis (TB) pose a challenge to achieving the goals set out in the tuberculosis eradication strategy and the SDGs by 2030. At present, timely and accessible early detection methods for tuberculosis are still a major obstacle. In th…
Phase: NA • Sponsor: Xuelin Yang • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Could less radiation be just as effective for neck cancer?
Disease control Recruiting nowBased on the pattern of nasopharyngeal carcinoma cervical lymph node metastasis, which typically follows a sequential downward spread with rare skip metastases and a tendency for ipsilateral neck involvement, and in accordance with the latest international guidelines, we propose …
Phase: PHASE3 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New combo therapy aims to slash deadly leaks after pancreatic cancer surgery
Disease control Recruiting nowThe PANENCA trial aims to reduce postoperative complications in patients undergoing pancreatoduodenectomy (also known as a Whipple procedure), a complex surgical operation performed to remove tumors located in or near the head of the pancreas. One of the most frequent and serious…
Phase: PHASE4 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New hope for brain lining cancer: spinal tap chemo after targeted drug fails
Disease control Recruiting nowPemetrexed is one of the first-line chemotherapeutic agents for non-squamous non-small cell lung cancer (NSCLC). Since 2017, intrathecal pemetrexed has shown good efficacy for patients with leptomeningeal metastases from NSCLC. It has been recommended as the preferred drug for in…
Phase: PHASE2 • Sponsor: Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
AI could spot pancreatic tumors faster and more accurately
Diagnosis Recruiting nowThe aim of this study is to validate an artificial intelligence system named iEUS-SPL(intelligent endoscopic ultrasound system-solid pancreatic lesion) for detecting and multimodal, multi-class diagnosing solid pancreatic lesions during endoscopic ultrasound(EUS) examination.
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
PrEP goes local: Community-Based HIV prevention trial launches in rio
Prevention Recruiting nowThis study aims to improve access to HIV prevention using pre-exposure prophylaxis (PrEP) among underserved populations in Rio de Janeiro, including gay and bisexual men, transgender women, and sex workers. Despite the proven effectiveness of PrEP, many people at higher risk of H…
Phase: NA • Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
2-Minute heart scan could transform emergency diagnosis of heart failure
Diagnosis Recruiting nowThis is a prospective, observational study conducted in the emergency department. Adult patients presenting with dyspnea will be enrolled, and study data will be collected from routine clinical assessments, including medical history, physical examination, laboratory tests, and ec…
Sponsor: CardioStory INC • Aim: Diagnosis
Last updated Jul 08, 2026 00:00 UTC
-
Can a cholesterol drug help immunotherapy fight colorectal cancer?
Disease control Recruiting nowMetastatic colorectal cancer with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) molecular phenotypes could significantly benefit from immune checkpoint inhibitor therapy, ushering in the MSI era of immunotherapy for colorectal cancer. However, MSI-H/…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC